Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

1. CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease

   Mujeeb Ur Rahman, Muhammad Bilal, Junaid Ali Shah +3

   Шарҳ мақолаCRISPR and Genetic EngineeringPharmaceutics20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.review-article.000012

2. Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

   Moeen F. Dababneh, Bahjat Alhasso, Abdulkareem Shareef +10

   МақолаLipoproteins and Cardiovascular HealthJournal of Pharmaceutical Innovation20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.013240